Drug helps maintain platelet inhibition and anti-clotting levels prior to cardiac surgery
Tuesday, January 17, 2012 - 16:31
in Health & Medicine
Patients who discontinued use of an antiplatelet agent such as clopidogrel prior to undergoing cardiac surgery to lower their bleeding risk and received intravenously the platelet inhibitor cangrelor achieved a higher rate of maintenance of platelet inhibition, compared to patients who received placebo, according to a study in the January 18 issue of JAMA.